Philip Starkey Lewis retweeted
NEW SIGNING 🚨
Please welcome back to the club, Jack Goodwin.
Another pivotal cog in our Promotion winning machine; Jack is a twice PCFC Young Player of the Season winner and transfers from @MarineAFC in the National League North.
Welcome back, @Jackgoodwin101
Philip Starkey Lewis retweeted
📢 Recruitment is now COMPLETE to both BOPPP & MBOP! 🥳🥳
A major THANK YOU from us to you ALL for your hard work to get us here! 💙💙💙
We exceeded our recruitment target with a TOTAL of 7️⃣6️⃣3️⃣ recruitment participants! A huge commitment - we couldn't have done it with you ALL!
Philip Starkey Lewis retweeted
Alcohol abstinence reduced #cirrhosis decompensation risk even in people with high portal pressure
1️⃣i ❤️good news
2️⃣study would have benefitted from peth
3️⃣👏👏first author Dr Hofer
#livertwitter
pubmed.ncbi.nlm.nih.gov/3648… @AGA_CGH
Philip Starkey Lewis retweeted
Resolution Therapeutics is featured in the latest blog by @LiverTrust!
This post highlights Resolution's EMERALD trial, following CTA approval from the MHRA and is set to begin enrolment by the end of 2024
Read the blog post here: britishlivertrust.org.uk/gre…
Philip Starkey Lewis retweeted
Precision mapping of a gut-brain circuit w/ functional impact.
Glands in the small intestine (Brunner's) have GLP-1 receptors, are stress-sensitive, connect to the brain via the vagal nerve, modulate bacterial species in the gut microbiome, and regulate immunity
cell.com/cell/fulltext/S0092… @CellCellPress
Cirrhosis of the liver still on the rise
Look how the leading causes of death in the US have changed over the past 4 years
@JAMA_current
jamanetwork.com/journals/jam…
10
Philip Starkey Lewis retweeted
What a day! Just finished my first ever @edfringe @CODIfringe performance. Brilliant questions from the audience and awesome support from @suziemo. Thanks to all for making this happen, such fun! @EdinUni_IRR
Philip Starkey Lewis retweeted
Another exciting day in IgA Nephropathy
novartis.com/news/media-rele…
Philip Starkey Lewis retweeted
Replying to @ResolutionTx @uniofedinburgh
Read more: resolution-tx.com/resolution…
Philip Starkey Lewis retweeted
Today we have announced key data presentations with the @uniofedinburgh at the #EASL Congress 2024, held in Milan, Italy.
The data highlights the significant potential of macrophage cell therapy for advanced liver cirrhosis.
Read the full press release below.
Philip Starkey Lewis retweeted
Watch our CEO @amirhefni on #OptimumTV discussing the urgent need for new treatments for end-stage liver disease and our innovative macrophage cell therapy platform!
Excited to present our poster at #EASL in Milan this week!
Watch the episode below.
End-stage liver disease is a cruel illness, compounded by the scarcity of donor livers needed to extend life.
In the latest edition of #OptimumTV with @ResolutionTx CEO @amirhefni, learn how the @EdinburghUni spin-out is developing a pioneering non-surgical treatment for end-stage #liver disease using autologous cell therapy. #ResolutionTherapeutics #OptimumStrategicCommunications
Philip Starkey Lewis retweeted
Our co-founder, Prof. Stuart Forbes from @EdinburghUni is presenting "Macrophage Therapy for Liver Disease" at the 3rd International Symposium on Regenerative Hepatology, organized by #EASL, in Milan today!
📅 Tuesday, 4 June | 🕔5 PM | 📍 Theatre 3
Don't miss it!
Philip Starkey Lewis retweeted
#LiverTwitter @EASLnews @AASLDtweets
Save the date
#BanenoVIII 27-28 March 2026
sign up for updates as a member for free:
🌐 bavenocoop.net/
@BavenoCoop
Philip Starkey Lewis retweeted
With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-harris…
Philip Starkey Lewis retweeted
So sad about the passing of Stephen Harrison, one of the most influential leaders in hepatology, and a great person.
His legacy, including the first drug for MASLD, his talent and his kind demeanor will remain with us.
#livertwitter @EASLnews @AASLDtweets
Philip Starkey Lewis retweeted
Tomorrow is #WorldLiverDay!
Liver disease poses a significant health and socio-economic burden globally, yet it lacks adequate attention on the global political agenda.
There is low awareness about liver disease risk factors at the population level.
Most liver diseases could be prevented.
🌎Let's spread awareness and address these gaps.
🎉 Celebrate #WorldLiverDay on 19 April, wherever in the world you are based.
👉worldliverday.org
#liver #health #awareness @EASLnews @AASLDtweets @APASLnews @alehlatam @Solda_Society @AleksanderKrag @EASLEUAffairs @JHepatology @JVLazarus @EASLedu @FattyLiverA @GlobalLiver @LiverPatients @EuropeLiver
Philip Starkey Lewis retweeted
Is this the first time that #cirrhosis made the pages of @WIRED?
wired.com/story/cells-grow-l…
Nice write up about the exciting world of cellular therapies for liver disease
Philip Starkey Lewis retweeted
REVIEW:
Mallet M et al. Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis.
#LiverTwitter
tinyurl.com/5n6ctww5
Philip Starkey Lewis retweeted
What is in the pipeline to treat decompensated cirrhosis ? Can we use biomarkers to guide therapy ?
This great review by giants in the field tells you all.
t.ly/DRBav #livertwitter @JonelTrebicka @DebbieShawcros1 @ruben_hernaez @Gut_BMJ



























